Search Results - Clemence Pouzin
- Showing 1 - 3 results of 3
-
1
Covariate analysis of tusamitamab ravtansine, a DM4 anti‐CEACAM5 antibody‐drug conjugate, based on first‐in‐human study by Clemence Pouzin, Michel Tod, Mustapha Chadjaa, Nathalie Fagniez, Laurent Nguyen
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
A multi‐model approach to predict efficacious clinical dose for an anti‐TGF‐β antibody (GC2008) in the treatment of osteogenesis imperfecta by Panteleimon D. Mavroudis, Nikhil Pillai, Qingping Wang, Clemence Pouzin, Benjamin Greene, Jennifer Fretland
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid... by Joaquina C. Baranda, Debbie Robbrecht, Ryan Sullivan, Bernard Doger, Armando Santoro, Minal Barve, Jean‐Jacques Grob, Oliver Bechter, Maria Vieito, Maria Jose deMiguel, Dirk Schadendorf, Melissa Johnson, Clemence Pouzin, Cathy Cantalloube, Rui Wang, Jooyun Lee, Xiaofei Chen, Brigitte Demers, Amele Amrate, Giovanni Abbadessa, F. Stephen Hodi
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book